Product information and disease descriptionProduct descriptionProduct information
Dosage forms and strengths
4 evidence topics · 5 sources
Investigational dosage form: 45 mg film-coated tablet for oral use
| Field | Quoted record |
|---|---|
| Product | “VX-147 film-coated tablet” |
| Pharmaceutical form | “FILM-COATED TABLET” |
| Route of administration | “ORAL USE” |
| Maximum daily dose | “45 mg milligram(s)” |
| Maximum total dose | “4860 mg milligram(s)” |
| Maximum duration of treatment | “108 week(s)” |
| Placebo | “VX-147, Coated Placebo Tablet” |
Tablet formulation development: relative bioavailability and food effect study
Commercial strengths and package sizes
No evidence found.